JPY 2560.0
(-0.58%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 81.94 Billion JPY | 6.2% |
2022 | 77.16 Billion JPY | 5.71% |
2021 | 72.99 Billion JPY | -9.27% |
2020 | 80.45 Billion JPY | 12.49% |
2019 | 71.52 Billion JPY | 43.29% |
2018 | 49.91 Billion JPY | 516.09% |
2017 | 8.1 Billion JPY | -20.96% |
2016 | 10.25 Billion JPY | -61.38% |
2015 | 26.54 Billion JPY | -19.65% |
2014 | 33.03 Billion JPY | 22.58% |
2013 | 26.94 Billion JPY | -7.46% |
2012 | 29.12 Billion JPY | -27.5% |
2011 | 40.16 Billion JPY | 645.89% |
2010 | 5.38 Billion JPY | 69.23% |
2009 | 3.18 Billion JPY | 39.07% |
2008 | 2.28 Billion JPY | -27.43% |
2007 | 3.15 Billion JPY | -56.45% |
2006 | 7.24 Billion JPY | -32.98% |
2005 | 10.8 Billion JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 70.1 Billion JPY | -14.45% |
2023 Q3 | 70.1 Billion JPY | 9.53% |
2023 Q1 | 66.3 Billion JPY | -14.08% |
2023 Q2 | 64 Billion JPY | -3.47% |
2023 FY | 81.94 Billion JPY | 6.2% |
2023 Q4 | 81.94 Billion JPY | 16.9% |
2022 Q2 | 55.51 Billion JPY | 0.0% |
2022 Q4 | 77.16 Billion JPY | 36.09% |
2022 Q3 | 56.7 Billion JPY | 2.14% |
2022 FY | 77.16 Billion JPY | 5.71% |
2022 Q1 | 55.51 Billion JPY | -23.96% |
2021 Q4 | 72.99 Billion JPY | 18.08% |
2021 Q1 | 63.9 Billion JPY | -20.57% |
2021 Q3 | 61.82 Billion JPY | -2.85% |
2021 Q2 | 63.63 Billion JPY | -0.43% |
2021 FY | 72.99 Billion JPY | -9.27% |
2020 Q2 | 74.28 Billion JPY | 0.98% |
2020 Q1 | 73.56 Billion JPY | 2.85% |
2020 Q3 | 72.46 Billion JPY | -2.45% |
2020 Q4 | 80.45 Billion JPY | 11.03% |
2020 FY | 80.45 Billion JPY | 12.49% |
2019 FY | 71.52 Billion JPY | 43.29% |
2019 Q4 | 71.52 Billion JPY | 15.43% |
2019 Q3 | 61.96 Billion JPY | 41.6% |
2019 Q2 | 43.75 Billion JPY | -2.81% |
2019 Q1 | 45.02 Billion JPY | -9.8% |
2018 Q1 | 47.29 Billion JPY | 483.79% |
2018 Q4 | 49.91 Billion JPY | 3.67% |
2018 FY | 49.91 Billion JPY | 516.09% |
2018 Q3 | 48.15 Billion JPY | 37.56% |
2018 Q2 | 35 Billion JPY | -26.0% |
2017 Q3 | 5.29 Billion JPY | 0.0% |
2017 FY | 8.1 Billion JPY | -20.96% |
2017 Q4 | 8.1 Billion JPY | 52.93% |
2017 Q2 | 5.29 Billion JPY | -15.88% |
2017 Q1 | 6.29 Billion JPY | -38.56% |
2016 Q2 | 19.29 Billion JPY | -4.93% |
2016 Q1 | 20.29 Billion JPY | -23.52% |
2016 Q3 | 17.29 Billion JPY | -10.36% |
2016 FY | 10.25 Billion JPY | -61.38% |
2016 Q4 | 10.25 Billion JPY | -40.74% |
2015 Q4 | 26.54 Billion JPY | 13.91% |
2015 FY | 26.54 Billion JPY | -19.65% |
2015 Q3 | 23.3 Billion JPY | -7.91% |
2015 Q2 | 25.3 Billion JPY | -19.17% |
2015 Q1 | 31.3 Billion JPY | -5.25% |
2014 Q3 | 18.25 Billion JPY | -9.88% |
2014 Q2 | 20.25 Billion JPY | -0.12% |
2014 FY | 33.03 Billion JPY | 22.58% |
2014 Q4 | 33.03 Billion JPY | 81.01% |
2014 Q1 | 20.27 Billion JPY | -24.76% |
2013 Q3 | 22.3 Billion JPY | -8.57% |
2013 Q2 | 24.39 Billion JPY | -0.23% |
2013 Q1 | 24.44 Billion JPY | -16.05% |
2013 FY | 26.94 Billion JPY | -7.46% |
2013 Q4 | 26.94 Billion JPY | 20.84% |
2012 Q4 | 29.12 Billion JPY | -12.77% |
2012 Q1 | 35.6 Billion JPY | -11.37% |
2012 Q3 | 33.38 Billion JPY | 9.29% |
2012 Q2 | 30.54 Billion JPY | -14.19% |
2012 FY | 29.12 Billion JPY | -27.5% |
2011 Q3 | 42.81 Billion JPY | 1365.4% |
2011 FY | 40.16 Billion JPY | 645.89% |
2011 Q2 | 2.92 Billion JPY | -9.9% |
2011 Q1 | 3.24 Billion JPY | -39.78% |
2011 Q4 | 40.16 Billion JPY | -6.2% |
2010 FY | 5.38 Billion JPY | 69.23% |
2010 Q3 | 3.84 Billion JPY | -3.03% |
2010 Q4 | 5.38 Billion JPY | 40.2% |
2010 Q2 | 3.96 Billion JPY | -1.61% |
2010 Q1 | 4.02 Billion JPY | 26.52% |
2009 Q3 | 796 Million JPY | -28.8% |
2009 FY | 3.18 Billion JPY | 39.07% |
2009 Q4 | 3.18 Billion JPY | 299.75% |
2009 Q2 | 1.11 Billion JPY | 0.0% |
2008 Q3 | 2.15 Billion JPY | 0.0% |
2008 FY | 2.28 Billion JPY | -27.43% |
2008 Q4 | 2.28 Billion JPY | 6.22% |
2007 FY | 3.15 Billion JPY | -56.45% |
2006 FY | 7.24 Billion JPY | -32.98% |
2005 FY | 10.8 Billion JPY | 0.0% |
2004 Q4 | 17.83 Billion JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 26.33 Billion JPY | -211.21% |
DNA Chip Research Inc. | - JPY | -Infinity% |
Cosmo Bio Company,Limited | 20 Million JPY | -409625.0% |
FALCO HOLDINGS Co., Ltd. | 817 Million JPY | -9929.988% |
BML, Inc. | 5.26 Billion JPY | -1456.41% |
Human Metabolome Technologies, Inc. | 226.3 Million JPY | -36110.302% |
Precision System Science Co., Ltd. | 1.36 Billion JPY | -5896.123% |